Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “HHT”

157 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 157 results

Testing effectiveness (Phase 2)Study completedNCT00375219
What this trial is testing

Homoharringtonine (Omacetaxine Mepesuccinate) in Treating Patients With Chronic Myeloid Leukemia (CML) With the T315I BCR-ABL Gene Mutation

Who this might be right for
Chronic Myeloid Leukemia
Teva Branded Pharmaceutical Products R&D, Inc. 103
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07643636
What this trial is testing

Chidamide, Venetoclax, Azacitidine, and Homoharringtonine for High-risk Fit AML

Who this might be right for
AML (Acute Myeloid Leukemia)
Dongguan People's Hospital 46
Not applicableStudy completedNCT06039124
What this trial is testing

Subsequent Bevacizumab Treatment in Patients With HHT. Follow up BABH

Who this might be right for
Hemorrhagic Hereditary TelangiectasiaHHT
Hospices Civils de Lyon 23
Testing effectiveness (Phase 2)Looking for participantsNCT04501120
What this trial is testing

Study of Lisaftoclax (APG-2575) Single Agent and Combination With Therapy in Patients Relapsed/Refractory AML

Who this might be right for
Relapsed/Refractory Acute Myeloid LeukaemiaMyeloid Malignancy
Ascentage Pharma Group Inc. 682
Large-scale testing (Phase 3)Not Yet RecruitingNCT07469046
What this trial is testing

VAH vs VA in Newly Diagnosed Elderly AML

Who this might be right for
Acute Myeloid Leukemia (AML)Elderly Patients (60-75 Years)
Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine 308
Testing effectiveness (Phase 2)Study completedNCT00375622
What this trial is testing

Anti-Estrogen Therapy for Hereditary Hemorrhagic Telangiectasia A Double-Blind Placebo-Controlled Clinical Trial

Who this might be right for
Hereditary Hemorrhagic Telangiectasia
Rabin Medical Center 60
Testing effectiveness (Phase 2)Ended earlyNCT02029417
What this trial is testing

Omacetaxine Mepesuccinate, Cytarabine, and Decitabine in Treating Older Patients With Newly Diagnosed Acute Myeloid Leukemia

Who this might be right for
Acute Myeloid Leukemia With Multilineage Dysplasia Following Myelodysplastic SyndromeAdult Acute Megakaryoblastic Leukemia (M7)Adult Acute Minimally Differentiated Myeloid Leukemia (M0)+14 more
Roswell Park Cancer Institute 2
Not applicableStudy completedNCT00004648
What this trial is testing

Studies of Hereditary Hemorrhagic Telangiectasia

Who this might be right for
Telangiectasia, Hereditary Hemorrhagic
National Center for Research Resources (NCRR) 65
Testing effectiveness (Phase 2)Study completedNCT03397004
What this trial is testing

Doxycycline for Hereditary Hemorrhagic Telangiectasia

Who this might be right for
Hereditary Hemorrhagic Telangiectasia (HHT)
Unity Health Toronto 13
Not applicableStudy completedNCT03691142
What this trial is testing

Evaluation of Obstetrical and Neonatal Complications in Hereditary Haemorrhagic Telangiectasia (HHT)

Who this might be right for
Osler Rendu DiseaseHereditary Hemorrhagic Telangiectasia
Hospices Civils de Lyon 207
Not applicableLooking for participantsNCT04194619
What this trial is testing

Pregnancy in Women With Rare Multisystemic Vascular Diseases: COGRare5 Study

Who this might be right for
Vascular AnomalyOsler Rendu DiseaseMarfan Syndrome or Related+3 more
Hospices Civils de Lyon 400
Early research (Phase 1)Not Yet RecruitingNCT07667413
What this trial is testing

Topical TOR-582 Treatment of Epistaxis in HHT

Who this might be right for
Hereditary Hemorrhagic Telangiectasia (HHT)Epistaxis
Columbia University 27
Not applicableActive Not RecruitingNCT06266624
What this trial is testing

Tourniquet-Test in HHT

Who this might be right for
HHT
University Hospital, Essen 92
Not applicableStudy completedNCT04396041
What this trial is testing

Microvascular Plug (MVP) for the Treatment of Pulmonary ArterioVenous Malformations (PAVMs)

Who this might be right for
Pulmonary Arteriovenous Malformation
Johns Hopkins University 223
Not applicableStudy completedNCT07018401
What this trial is testing

Pomalidomide for the Treatment of Bleeding in Hereditary Hemorrhagic Telangiectasia Longitudinal Assessment Study

Who this might be right for
Hereditary Hemorrhagic Telangiectasia (HHT)
Massachusetts General Hospital 62
Large-scale testing (Phase 3)Study completedNCT00355108
What this trial is testing

ATERO : A Randomised Study With Tranexamic Acid in Epistaxis of Rendu Osler Syndrome

Who this might be right for
Telangiectasia, Hereditary HemorrhagicOsler-Rendu Disease
Hospices Civils de Lyon 170
Large-scale testing (Phase 3)Ended earlyNCT02106520
What this trial is testing

Efficacy of a Bevacizumab Nasal Spray as a Treatment for Epistaxis in Hereditary Hemorrhagic Telangiectasia (HHT)

Who this might be right for
Hereditary Hemorrhagic TelangiectasiaEpistaxis
Hospices Civils de Lyon 80
Not applicableStudy completedNCT01158807
What this trial is testing

Cerebral Hemorrhage Risk in Hereditary Hemorrhagic Telangiectasia

Who this might be right for
Hereditary Hemorrhagic Telangiectasia
Unity Health Toronto 2,272
Testing effectiveness (Phase 2)Study completedNCT00462943
What this trial is testing

Open Label Study of Subcutaneous Homoharringtonine (Omacetaxine Mepesuccinate) in Patients With Advanced CML

Who this might be right for
Chronic Myeloid Leukemia
Teva Branded Pharmaceutical Products R&D, Inc. 100
Testing effectiveness (Phase 2)Study completedNCT03910244
What this trial is testing

Pomalidomide for the Treatment of Bleeding in HHT

Who this might be right for
Telangiectasia, Hereditary Hemorrhagic
The Cleveland Clinic 145
Next Page